PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16965596

Serologic testing for human T-lymphotropic virus-3 and -4.

William M Switzer·Indira Hewlett·Leslyn Aaron·Nathan D Wolfe·Donald S Burke·Walid Heneine
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

DeltaretrovirusDeltaretrovirus InfectionsHTLV-I AntibodiesHumansImmunoenzyme TechniquesSerologic TestsSerotypingLetter

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

William M Switzer, Indira Hewlett, Leslyn Aaron, Nathan D Wolfe, Donald S Burke, Walid Heneine. 2006. Serologic testing for human T-lymphotropic virus-3 and -4.. https://doi.org/10.1111/j.1537-2995.2006.00950.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

[Human T lymphotropic virus: from molecular epidemiology to disease].

Human T lymphotropic virus (HTLV) is a retrovirus presenting several novel features. Although the dominant modes of transmission are conventional, i.e., blood-borne, sexual and mother-to-child, HTLV), the distribution of HTLV infection is highly variable within human populations. Unlike HIV, the genome of HTLV shows low variability but, like HIV, HTLV originates from old world monkeys and apes. Although the virus can induce severe diseases, this course is observed in only a small number of infected people. Determinant factors for development of adult T cell leukemia (ATL) and tropical spastic paraparesis (TSP) are complex and treatment outcomes have been disappointing.

Deltaretrovirus↗